Pharmacoeconomic considerations in the treatment of breast cancer.
about
Clinical considerations for the development of biosimilars in oncologyPatterns of resource utilization and cost for postmenopausal women with hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer in EuropeCost of treatment for breast cancer in central Vietnam.
P2860
Pharmacoeconomic considerations in the treatment of breast cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pharmacoeconomic considerations in the treatment of breast cancer.
@ast
Pharmacoeconomic considerations in the treatment of breast cancer.
@en
type
label
Pharmacoeconomic considerations in the treatment of breast cancer.
@ast
Pharmacoeconomic considerations in the treatment of breast cancer.
@en
prefLabel
Pharmacoeconomic considerations in the treatment of breast cancer.
@ast
Pharmacoeconomic considerations in the treatment of breast cancer.
@en
P2093
P2860
P1476
Pharmacoeconomic considerations in the treatment of breast cancer.
@en
P2093
Athanasios Pallis
Nikos Maniadakis
Vasiliki Tsiantou
P2860
P407
P577
2010-06-15T00:00:00Z